Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05193318 · ClinicalTrials.gov registry record · Phase 2
KAP for Depression in Abstinent Opioid Users
A Phase 2 study, sponsored by Medical University of South Carolina.
- Terminated
- Registry status
- Phase 2
- Development phase
- 5
- Enrollment target
NCT05193318 is a Phase 2 study that was terminated before completion, run by Medical University of South Carolina. The registered enrollment target is 5 participants.
The verdict
NCT05193318, a Phase 2 study, was terminated before completion, sponsored by Medical University of South Carolina.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 5 participants
- Enrollment target
Study Summary
The purpose of the study is to examine whether an investigational medication called ketamine along with psychotherapy is an effective treatment for depression in participants with a history of opioid addiction who have not abused opioids in at least 3 months. Participants will receive ketamine through intramuscular injection along with psychotherapy weekly for 8 weeks. Participation for eligible subjects who decide to enroll (including post-medication follow-up visits) will last about 16 weeks or 4 months.
Interventions
- DRUG Ketamine-assisted psychotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2022-01-13 |
| Est. Completion | 2023-03-20 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05193318
The ClinicalTrials.gov registry entry for NCT05193318 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ketamine-assisted psychotherapy is the first listed.
NCT05193318 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05193318 about?
NCT05193318 is a clinical study titled "KAP for Depression in Abstinent Opioid Users". The purpose of the study is to examine whether an investigational medication called ketamine along with psychotherapy is an effective treatment for depression in participants with a history of opioid addiction who have not abused opioids in at least 3 months. Participants will receive ketamine throu...
What is the current status of trial NCT05193318?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 5 participants. The study started on 2022-01-13. Estimated completion is 2023-03-20.
What interventions are being tested in trial NCT05193318?
The interventions under investigation include: Ketamine-assisted psychotherapy (DRUG).
Who is sponsoring clinical trial NCT05193318?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.